Post-earnings recap
Reported
Tue, Mar 6, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
PTC Therapeutics reported a positive earnings surprise, with EPS significantly exceeding expectations. The stock reacted positively, rising by 0.68%. However, the lack of revenue data and guidance leaves some uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.03 | N/A | +149.26% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the earnings performance despite not providing specific revenue figures. They emphasized their commitment to advancing their pipeline.
The company is pleased with the positive EPS surprise.
Management highlighted ongoing efforts in product development.